Cargando…

The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study

BACKGROUND: Previous works have observed that younger infants with chronic hepatitis B virus (HBV) infection are more responsive to antiviral treatment. However, the underlying mechanism remains unclear. In this study, the dynamic changes of HBV quasispecies in infants with immunoprophylaxis failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi, Xiao, Yiwei, Li, Lili, Song, Yarong, Zhai, Xiangjun, Liu, Jianxun, Duan, Zhongping, Yan, Ling, Ding, Feng, Liu, Jia, Zhu, Liguo, Jiang, Jie, Zou, Huaibin, Li, Lingxiang, Liang, Caihong, Wang, Jie, Li, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628401/
https://www.ncbi.nlm.nih.gov/pubmed/34844612
http://dx.doi.org/10.1186/s12985-021-01707-9
_version_ 1784606999433969664
author Li, Yi
Xiao, Yiwei
Li, Lili
Song, Yarong
Zhai, Xiangjun
Liu, Jianxun
Duan, Zhongping
Yan, Ling
Ding, Feng
Liu, Jia
Zhu, Liguo
Jiang, Jie
Zou, Huaibin
Li, Lingxiang
Liang, Caihong
Wang, Jie
Li, Jie
author_facet Li, Yi
Xiao, Yiwei
Li, Lili
Song, Yarong
Zhai, Xiangjun
Liu, Jianxun
Duan, Zhongping
Yan, Ling
Ding, Feng
Liu, Jia
Zhu, Liguo
Jiang, Jie
Zou, Huaibin
Li, Lingxiang
Liang, Caihong
Wang, Jie
Li, Jie
author_sort Li, Yi
collection PubMed
description BACKGROUND: Previous works have observed that younger infants with chronic hepatitis B virus (HBV) infection are more responsive to antiviral treatment. However, the underlying mechanism remains unclear. In this study, the dynamic changes of HBV quasispecies in infants with immunoprophylaxis failure were investigated to provide virological explanations for clinical management on infantile antiviral therapy. METHODS: Thirteen 7-month-old infants with immunoprophylaxis failure and their mothers were enrolled from a prospective cohort, and 8 of them were followed up to 3 years old. The sequences of HBV quasispecies were analyzed by the full-length genome clone-based sequencing, and compared among mothers and their infants at different ages. RESULTS: The results revealed that the complexity, mutation frequency and genetic distance of HBV quasispecies decreased significantly at full-length, partial open reading frames and regulatory regions of HBV genome at nucleotide level in 7-month-old infants comparing with their mothers, whereas increased significantly to near the maternal level when infants grew up to 3 years old. Furthermore, similar changes were also found in Core, PreS2, RT and P regions of HBV genome at amino acid level, especially for potential NAs-resistant mutants in RT region and immune-escape mutants in Core and PreS2 regions. CONCLUSIONS: This study uncovered the evolution of HBV quasispecies in infancy after mother-to-child transmission, which may provide the virological evidence for explaning that younger children are more responsive to antiviral therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-021-01707-9.
format Online
Article
Text
id pubmed-8628401
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86284012021-12-01 The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study Li, Yi Xiao, Yiwei Li, Lili Song, Yarong Zhai, Xiangjun Liu, Jianxun Duan, Zhongping Yan, Ling Ding, Feng Liu, Jia Zhu, Liguo Jiang, Jie Zou, Huaibin Li, Lingxiang Liang, Caihong Wang, Jie Li, Jie Virol J Research BACKGROUND: Previous works have observed that younger infants with chronic hepatitis B virus (HBV) infection are more responsive to antiviral treatment. However, the underlying mechanism remains unclear. In this study, the dynamic changes of HBV quasispecies in infants with immunoprophylaxis failure were investigated to provide virological explanations for clinical management on infantile antiviral therapy. METHODS: Thirteen 7-month-old infants with immunoprophylaxis failure and their mothers were enrolled from a prospective cohort, and 8 of them were followed up to 3 years old. The sequences of HBV quasispecies were analyzed by the full-length genome clone-based sequencing, and compared among mothers and their infants at different ages. RESULTS: The results revealed that the complexity, mutation frequency and genetic distance of HBV quasispecies decreased significantly at full-length, partial open reading frames and regulatory regions of HBV genome at nucleotide level in 7-month-old infants comparing with their mothers, whereas increased significantly to near the maternal level when infants grew up to 3 years old. Furthermore, similar changes were also found in Core, PreS2, RT and P regions of HBV genome at amino acid level, especially for potential NAs-resistant mutants in RT region and immune-escape mutants in Core and PreS2 regions. CONCLUSIONS: This study uncovered the evolution of HBV quasispecies in infancy after mother-to-child transmission, which may provide the virological evidence for explaning that younger children are more responsive to antiviral therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-021-01707-9. BioMed Central 2021-11-29 /pmc/articles/PMC8628401/ /pubmed/34844612 http://dx.doi.org/10.1186/s12985-021-01707-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Yi
Xiao, Yiwei
Li, Lili
Song, Yarong
Zhai, Xiangjun
Liu, Jianxun
Duan, Zhongping
Yan, Ling
Ding, Feng
Liu, Jia
Zhu, Liguo
Jiang, Jie
Zou, Huaibin
Li, Lingxiang
Liang, Caihong
Wang, Jie
Li, Jie
The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study
title The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study
title_full The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study
title_fullStr The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study
title_full_unstemmed The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study
title_short The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study
title_sort dynamic changes of hbv quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628401/
https://www.ncbi.nlm.nih.gov/pubmed/34844612
http://dx.doi.org/10.1186/s12985-021-01707-9
work_keys_str_mv AT liyi thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT xiaoyiwei thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT lilili thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT songyarong thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT zhaixiangjun thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT liujianxun thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT duanzhongping thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT yanling thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT dingfeng thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT liujia thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT zhuliguo thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT jiangjie thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT zouhuaibin thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT lilingxiang thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT liangcaihong thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT wangjie thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT lijie thedynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT liyi dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT xiaoyiwei dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT lilili dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT songyarong dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT zhaixiangjun dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT liujianxun dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT duanzhongping dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT yanling dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT dingfeng dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT liujia dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT zhuliguo dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT jiangjie dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT zouhuaibin dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT lilingxiang dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT liangcaihong dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT wangjie dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy
AT lijie dynamicchangesofhbvquasispeciesdiversityininfancyafterimmunoprophylaxisfailureaprospectivecohortstudy